BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32537765)

  • 1. Cutaneous leiomyosarcoma: dermal and subcutaneous.
    Wong GN; Webb A; Gyorki D; McCormack C; Tran P; Ngan SY; Slavin J; Henderson MA
    Australas J Dermatol; 2020 Aug; 61(3):243-249. PubMed ID: 32537765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous leiomyosarcoma: a retrospective review of 45 cases.
    Khan S; Asher R; Perkins W; Matin RN
    Clin Exp Dermatol; 2023 Dec; 49(1):2-8. PubMed ID: 37595134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes.
    Winchester DS; Hocker TL; Brewer JD; Baum CL; Hochwalt PC; Arpey CJ; Otley CC; Roenigk RK
    J Am Acad Dermatol; 2014 Nov; 71(5):919-25. PubMed ID: 25174541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leiomyosarcoma of the skin: review of the literature with an emphasis on prognosis and management.
    Kazlouskaya V; Lai YC; Khachemoune A
    Int J Dermatol; 2020 Feb; 59(2):165-172. PubMed ID: 31729020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome of superficial leiomyosarcoma.
    Wellings EP; Tibbo ME; Rose PS; Folpe AL; Houdek MT
    J Surg Oncol; 2021 Jan; 123(1):127-132. PubMed ID: 33063336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous and subcutaneous leiomyosarcoma: report of two cases].
    Pasquali P; Freites-Martinez A; Hernandez C; Valero Lugo J; Fortuño Á
    Dermatol Online J; 2014 Dec; 21(3):. PubMed ID: 25780967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors.
    Aneiros-Fernandez J; Antonio Retamero J; Husein-Elahmed H; Ovalle F; Aneiros-Cachaza J
    Eur J Dermatol; 2016; 26(1):9-12. PubMed ID: 26678649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal leiomyosarcoma demonstrate a predilection for distant recurrence and poor response to systemic treatments.
    Smrke A; Benson C; Strauss DC; Hayes AJ; Thway K; Hallin M; Fisher C; Messiou C; Huang PH; Jones RL; Smith MJ
    Eur J Surg Oncol; 2021 Oct; 47(10):2595-2601. PubMed ID: 33966946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S1-guideline cutaneous and subcutaneous leiomyosarcoma.
    Helbig D; Dippel E; Erdmann M; Frisman A; Kage P; Leiter U; Mentzel T; Seidel C; Weishaupt C; Ziemer M; Ugurel S
    J Dtsch Dermatol Ges; 2023 May; 21(5):555-563. PubMed ID: 36999582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases.
    Massi D; Franchi A; Alos L; Cook M; Di Palma S; Enguita AB; Ferrara G; Kazakov DV; Mentzel T; Michal M; Panelos J; Rodriguez-Peralto JL; Santucci M; Tragni G; Zioga A; Dei Tos AP
    Histopathology; 2010 Jan; 56(2):251-62. PubMed ID: 20102404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous leiomyosarcoma. A histological and immunohistochemical study of 9 cases, with ultrastructural correlation.
    Swanson PE; Stanley MW; Scheithauer BW; Wick MR
    J Cutan Pathol; 1988 Jun; 15(3):129-41. PubMed ID: 3294254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous Leiomyosarcoma: An Aggressive Malignancy Portending a Significant Risk of Metastasis and Death.
    Bresler SC; Gosnell HL; Ko JS; Angeles CV; Ronen S; Billings SD; Patel RM
    Am J Surg Pathol; 2023 Dec; 47(12):1417-1424. PubMed ID: 37727934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leiomyosarcoma and Pleomorphic Dermal Sarcoma: Guidelines for Diagnosis and Treatment.
    Llombart B; Serra-Guillén C; Requena C; Alsina M; Morgado-Carrasco D; Machado I; Sanmartín O
    Actas Dermosifiliogr (Engl Ed); 2019; 110(1):4-11. PubMed ID: 30409380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".
    Kraft S; Fletcher CD
    Am J Surg Pathol; 2011 Apr; 35(4):599-607. PubMed ID: 21358302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent cutaneous leiomyosarcoma.
    Wascher RA; Lee MY
    Cancer; 1992 Jul; 70(2):490-2. PubMed ID: 1617597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
    Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Varying characteristics of subcutaneous and dermal leiomyosarcomas. Two case reports and literature review].
    Seemann N; Lehmann P
    Hautarzt; 2006 May; 57(5):428-33. PubMed ID: 15856144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous leiomyosarcoma: a 20-year retrospective study and review of the literature.
    Soares Queirós C; Filipe P; Soares de Almeida L
    An Bras Dermatol; 2021; 96(3):278-283. PubMed ID: 33775481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous leiomyosarcoma on the face.
    Lin JY; Tsai RY
    Dermatol Surg; 1999 Jun; 25(6):489-91. PubMed ID: 10469099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous leiomyosarcoma.
    Ikari Y; Tokuhashi I; Haramoto I; Morita M; Chiba T; Shimoda N; Mizoguchi M; Seki K; Tadokoro M; Ohya K
    J Dermatol; 1992 Feb; 19(2):99-104. PubMed ID: 1377726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.